Literature DB >> 12802008

Protein tyrosine phosphatase RQ is a phosphatidylinositol phosphatase that can regulate cell survival and proliferation.

A Oganesian1, M Poot, G Daum, S A Coats, M B Wright, R A Seifert, D F Bowen-Pope.   

Abstract

Protein tyrosine phosphatase RQ (PTPRQ) was initially identified as a protein tyrosine phosphatase (PTPase)-like protein that is upregulated in a model of renal injury. Here we present evidence that, like PTEN, the biologically important enzymatic activity of PTPRQ is as a phosphatidylinositol phosphatase (PIPase). The PIPase specificity of PTPRQ is broader than that of PTEN and depends on different amino acid residues in the catalytic domain. In vitro, the recombinant catalytic domain of PTPRQ has low PTPase activity against tyrosine-phosphorylated peptide and protein substrates but can dephosphorylate a broad range of phosphatidylinositol phosphates, including phosphatidylinositol 3,4,5-trisphosphate and most phosphatidylinositol monophosphates and diphosphates. Phosphate can be hydrolyzed from the D3 and D5 positions in the inositol ring. PTPRQ does not have either of the basic amino acids in the catalytic domain that are important for the PIPase activity of PTEN or the sequence motifs that are characteristic of type II phosphatidylinositol 5-phosphatases. Instead, the PIPase activity depends on the WPE sequence present in the catalytic cleft of PTPRQ, and in the "inactive" D2 domains of many dual-domain PTPases, in place of the WPD motif present in standard active PTPases. Overexpression of PTPRQ in cultured cells inhibits proliferation and induces apoptosis. An E2171D mutation that retains or increases PTPase activity but eliminates PIPase activity, eliminates the inhibitory effects on proliferation and apoptosis. These results indicate that PTPRQ represents a subtype of the PTPases whose biological activities result from its PIPase activity rather than its PTPase activity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12802008      PMCID: PMC164626          DOI: 10.1073/pnas.1336511100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  An assay for phosphoinositide phosphatases utilizing fluorescent substrates.

Authors:  G S Taylor; J E Dixon
Journal:  Anal Biochem       Date:  2001-08-01       Impact factor: 3.365

Review 2.  Structural and evolutionary relationships among protein tyrosine phosphatase domains.

Authors:  J N Andersen; O H Mortensen; G H Peters; P G Drake; L F Iversen; O H Olsen; P G Jansen; H S Andersen; N K Tonks; N P Møller
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

3.  The myotubularin family: from genetic disease to phosphoinositide metabolism.

Authors:  J Laporte; F Blondeau; A Buj-Bello; J L Mandel
Journal:  Trends Genet       Date:  2001-04       Impact factor: 11.639

4.  Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway.

Authors:  S Ramaswamy; N Nakamura; F Vazquez; D B Batt; S Perera; T M Roberts; W R Sellers
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

5.  Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate.

Authors:  G S Taylor; T Maehama; J E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 6.  Synthesis and function of 3-phosphorylated inositol lipids.

Authors:  B Vanhaesebroeck; S J Leevers; K Ahmadi; J Timms; R Katso; P C Driscoll; R Woscholski; P J Parker; M D Waterfield
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 7.  PTEN and myotubularin: novel phosphoinositide phosphatases.

Authors:  T Maehama; G S Taylor; J E Dixon
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

8.  Crystal structure of the PTEN tumor suppressor: implications for its phosphoinositide phosphatase activity and membrane association.

Authors:  J O Lee; H Yang; M M Georgescu; A Di Cristofano; T Maehama; Y Shi; J E Dixon; P Pandolfi; N P Pavletich
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

9.  Simultaneous analysis of surface marker expression and cell cycle progression in human peripheral blood mononuclear cells.

Authors:  M T Rosato; A J Jabbour; R A Ponce; T J Kavanagh; T K Takaro; J P Hill; M Poot; P S Rabinovitch; E M Faustman
Journal:  J Immunol Methods       Date:  2001-10-01       Impact factor: 2.303

10.  The lipid phosphatase SHIP2 controls insulin sensitivity.

Authors:  S Clément; U Krause; F Desmedt; J F Tanti; J Behrends; X Pesesse; T Sasaki; J Penninger; M Doherty; W Malaisse; J E Dumont; Y Le Marchand-Brustel; C Erneux; L Hue; S Schurmans
Journal:  Nature       Date:  2001-01-04       Impact factor: 49.962

View more
  37 in total

Review 1.  Role of protein tyrosine phosphatases in cancer.

Authors:  Tasneem Motiwala; Samson T Jacob
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

Review 2.  The micromachinery of mechanotransduction in hair cells.

Authors:  Melissa A Vollrath; Kelvin Y Kwan; David P Corey
Journal:  Annu Rev Neurosci       Date:  2007       Impact factor: 12.449

3.  Ecto-5'-nucleotidase and intestinal ion secretion by enteropathogenic Escherichia coli.

Authors:  John K Crane; Irina Shulgina; Tonniele M Naeher
Journal:  Purinergic Signal       Date:  2007-05-17       Impact factor: 3.765

4.  Substrate specificity of R3 receptor-like protein-tyrosine phosphatase subfamily toward receptor protein-tyrosine kinases.

Authors:  Juichi Sakuraba; Takafumi Shintani; Sachiko Tani; Masaharu Noda
Journal:  J Biol Chem       Date:  2013-06-28       Impact factor: 5.157

5.  Novel PTPRQ mutations identified in three congenital hearing loss patients with various types of hearing loss.

Authors:  Naoko Sakuma; Hideaki Moteki; Hela Azaiez; Kevin T Booth; Masahiro Takahashi; Yasuhiro Arai; A Eliot Shearer; Christina M Sloan; Shin-Ya Nishio; Diana L Kolbe; Satoshi Iwasaki; Nobuhiko Oridate; Richard J H Smith; Shin-Ichi Usami
Journal:  Ann Otol Rhinol Laryngol       Date:  2015-03-18       Impact factor: 1.547

6.  Structural and biochemical characterization of Siw14: A protein-tyrosine phosphatase fold that metabolizes inositol pyrophosphates.

Authors:  Huanchen Wang; Chunfang Gu; Ronda J Rolfes; Henning J Jessen; Stephen B Shears
Journal:  J Biol Chem       Date:  2018-03-14       Impact factor: 5.157

7.  Association mapping of the high-grade myopia MYP3 locus reveals novel candidates UHRF1BP1L, PTPRR, and PPFIA2.

Authors:  Felicia Hawthorne; Sheng Feng; Ravikanth Metlapally; Yi-Ju Li; Khanh-Nhat Tran-Viet; Jeremy A Guggenheim; Francois Malecaze; Patrick Calvas; Thomas Rosenberg; David A Mackey; Cristina Venturini; Pirro G Hysi; Christopher J Hammond; Terri L Young
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-21       Impact factor: 4.799

Review 8.  Review series: The cell biology of hearing.

Authors:  Martin Schwander; Bechara Kachar; Ulrich Müller
Journal:  J Cell Biol       Date:  2010-07-12       Impact factor: 10.539

9.  The neurosecretory vesicle protein phogrin functions as a phosphatidylinositol phosphatase to regulate insulin secretion.

Authors:  Leslie A Caromile; Anush Oganesian; Scott A Coats; Ronald A Seifert; Daniel F Bowen-Pope
Journal:  J Biol Chem       Date:  2010-01-22       Impact factor: 5.157

Review 10.  Genetics of peripheral vestibular dysfunction: lessons from mutant mouse strains.

Authors:  Sherri M Jones; Timothy A Jones
Journal:  J Am Acad Audiol       Date:  2014-03       Impact factor: 1.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.